Patents by Inventor Per Bendix
Per Bendix has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10912757Abstract: The invention relates to a composition comprising isoflavones from red clover. The red clover extract has been fermented to obtain a composition comprising aglycone isoflavones. The fermentation is preferably performed by a lactic acid bacteria or fermented dandelion extract.Type: GrantFiled: July 16, 2018Date of Patent: February 9, 2021Assignee: HERRENS MARK APSInventors: Michael Mohr Jensen, Per Bendix Jeppesen, Max Norman Tandrup Lambert, Anne Cathrine Sonderstgaard Thorup
-
Patent number: 10328048Abstract: A method is provided of treating, preventing or ameliorating type 2 diabetes and/or a clinical condition associated with type 2 diabetes, which method comprises administering an effective amount of cafestol or a derivative thereof including esters and salts thereof to a person in need thereof. Further provided are compositions comprising cafestol and at least one additional agent suitable for treating, preventing or ameliorating diabetes and/or a clinical condition associated with diabetes. A method is also provided of increasing insulin secretion and/or increasing insulin-dependent glucose uptake, said method comprising administering an effective amount of cafestol or a derivative thereof to a person in need thereof.Type: GrantFiled: June 1, 2015Date of Patent: June 25, 2019Assignees: Aarhus Universitet, Region MidtjyllandInventors: Søren Gregersen, Per Bendix Jeppesen, Kjeld Hermansen, Fredrik Brustad Mellbye
-
Publication number: 20190008893Abstract: The present invention relates to a composition comprising a mixture of a polymeric biguanide polymer and an alkyl and/or dialkyl oxyethylene methyl ammonium salt for use as a medicament, in particular for use in treating, preventing or ameliorating a fungal disease such as aspergillosis. The present invention provides a method of treating, preventing and/or ameliorating a medical condition comprising administering the composition of the present invention to a human or animal in need thereof. A mechanical device comprising said composition is also provided.Type: ApplicationFiled: December 23, 2016Publication date: January 10, 2019Inventor: Per Bendix JEPPESEN
-
Publication number: 20180333387Abstract: The invention relates to a composition comprising isoflavones from red clover. The red clover extract has been fermented to obtain a composition comprising aglycone isoflavones. The fermentation is preferably performed by a lactic acid bacteria or fermented dandelion extract.Type: ApplicationFiled: July 16, 2018Publication date: November 22, 2018Applicant: HERRENS MARK APSInventors: Michael Mohr JENSEN, Per Bendix JEPPESEN, Max Norman Tandrup LAMBERT, Anne Cathrine Sonderstgaard THORUP
-
Publication number: 20180249713Abstract: The present invention concerns a composition comprising a combination of biocides having synergistic effect. The composition is useful for plant protection, in particular the composition is useful as a biocide, such as a pesticide, e.g. useful as a fungicide. The composition can be used alone or in combination with other pesticides/fungicides for plant protection by enhancing the effect of said other pesticide/fungicide.Type: ApplicationFiled: September 1, 2016Publication date: September 6, 2018Inventors: Dan Mønster NIELSEN, Per Bendix Jeppesen
-
Patent number: 9872871Abstract: The present invention relates to compositions comprising a steviol glycoside for use in restoring muscle glycogen by increasing the rate of glycogen re-synthesis in muscles that are depleted in glycogen due to exhaustive exercise and/or for use in treatment of muscle mass by increasing the rate of protein synthesis in muscles that are depleted in protein mass.Type: GrantFiled: April 22, 2014Date of Patent: January 23, 2018Assignee: Aarhus UniversitetInventors: Per Bendix Jeppesen, Søren Lavrsen
-
Publication number: 20170231946Abstract: A method is provided of treating, preventing or ameliorating type 2 diabetes and/or a clinical condition associated with type 2 diabetes, which method comprises administering an effective amount of cafestol or a derivative thereof including esters and salts thereof to a person in need thereof. Further provided are compositions comprising cafestol and at least one additional agent suitable for treating, preventing or ameliorating diabetes and/or a clinical condition associated with diabetes. A method is also provided of increasing insulin secretion and/or increasing insulin-dependent glucose uptake, said method comprising administering an effective amount of cafestol or a derivative thereof to a person in need thereof.Type: ApplicationFiled: June 1, 2015Publication date: August 17, 2017Inventors: Søren Gregersen, Per Bendix Jeppesen, Kjeld Hermansen, Fredrik Brustad Mellbye
-
Patent number: 9719057Abstract: A biocidal composition is provided, which comprise a mixture of the biocides Poly-(hexamethylene-guanidium chloride) and N,N-didecyl-N-methyl-poly(oxyethyl) ammonium propionate, which biocides have a synergistic biocidal effect against bacteria and fungi. Specifically, the provided composition can be as disinfectants and general biocidal products; preservatives; pest control; control; preservatives for food or feedstocks; antifouling products; embalming and taxidermist fluids; and control of other vertebrates; vermin control on domestic animals, livestock or pets; alga control; and products for use in spas or swimming pools.Type: GrantFiled: September 30, 2015Date of Patent: August 1, 2017Assignee: Liquid Vanity ApSInventors: Dan Mønster Nielsen, Per Bendix Jeppesen, Allan Korsgaard Poulsen
-
Patent number: 9636314Abstract: A dietary supplement or medicament comprising a substance including the chemical structure of bicyclo [3.2.1]octan or the chemical structure of kaurene. The medicament is useful for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The possible substances include steviol, isosteviol or stevioside.Type: GrantFiled: June 13, 2013Date of Patent: May 2, 2017Assignee: Stevia LimitedInventors: Kjeld Hermansen, Soren Gregersen, Per Bendix Jeppesen
-
Patent number: 9314438Abstract: The present invention relates to the use of isosteviol, steviol, and related compounds for elevating the plasma HDL-cholesterol level. The invention furthermore relates to the use of these compounds for reducing the body weight of a subject and/or lowering the plasma triglyceride level of a subject, including a concomitant elevation of the plasma HDL-cholesterol level. Preferably the compounds used are isosteviol and/or steviol, or pharmaceutically acceptable salts, solvates or prodrugs thereof. The compounds may furthermore be administered in combination with one or more further active compounds, such as e.g. LDL-cholesterol lowering agents. The invention furthermore relates to a method for elevating the plasma HDL-cholesterol level in a subject by administering to a subject in need of such treatment a plasma HDL-cholesterol level elevating amount of the compounds, described herein.Type: GrantFiled: December 5, 2008Date of Patent: April 19, 2016Assignees: Aarhus Universitet, Region MidtjyllandInventors: Kjeld Hermansen, Per Bendix Jeppesen
-
Publication number: 20160074424Abstract: The present invention relates to compositions comprising a steviol glycoside for use in restoring muscle glycogen by increasing the rate of glycogen re-synthesis in muscles that are depleted in glycogen due to exhaustive exercise and/or for use in treatment of muscle mass by increasing the rate of protein synthesis in muscles that are depleted in protein mass.Type: ApplicationFiled: April 22, 2014Publication date: March 17, 2016Applicant: AARHUS UNIVERSITETInventors: Per Bendix JEPPESEN, Søren LAVRSEN
-
Publication number: 20160017262Abstract: The present invention provides synergistic biocidal composition such as a synergistic detergent composition for use, e.g.Type: ApplicationFiled: September 30, 2015Publication date: January 21, 2016Inventors: Dan Nyenstad Mønster, Per Bendix Jeppesen, Torben Ballegaard Sørensen
-
Publication number: 20160000747Abstract: The invention relates to a composition comprising isoflavones from red clover. The red clover extract has been fermented to obtain a composition comprising aglycone isoflavones. The fermentation is preferably performed by a lactic acid bacteria or fermented dandelion extract.Type: ApplicationFiled: December 12, 2013Publication date: January 7, 2016Applicant: Herrens Mark ApSInventors: Michael Mohr Jensen, Per Bendix JEPPESEN, Max Norman Tandrup LAMBERT, Anne Cathrine Sonderstgaard THORUP
-
Publication number: 20140094408Abstract: A dietary supplement or medicament comprising a substance including the chemical structure of bicyclo [3.2.1]octan or the chemical structure of kaurene. The medicament is useful for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The possible substances include steviol, isosteviol or stevioside.Type: ApplicationFiled: June 13, 2013Publication date: April 3, 2014Inventors: Kjeld Hermansen, Soren Gregersen, Per Bendix Jeppesen
-
Publication number: 20130216625Abstract: The present invention relates to the use of a substance with the core structure of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the manufacture of a composition for the treatment of insulin resistance or diseases associated with insulin resistance, preferably in human subject in a daily dosage in a range of from about 5 mg to about 1500 mg. The invention furthermore relates to a method of treating insulin resistance or diseases associated with insulin resistance in a mammal, said method comprises administering to said mamma, preferably a human subject, a substance with the core structure of formula (I), preferably in a daily dosage in a range from about 5 mg to about 1500 mg. The substance is preferably isosteviol or steviol, or pharmaceutically acceptable salts, solvates or prodrugs thereof. Examples of diseases associated with insulin resistance and e.g.Type: ApplicationFiled: September 14, 2012Publication date: August 22, 2013Applicant: STEVIA APSInventors: Kjeld Hermansen, Per Bendix Jeppesen
-
Publication number: 20130177518Abstract: The present invention provides synergistic biocidal composition such as a synergistic detergent composition for use e.g. in disinfection and cleaning.Type: ApplicationFiled: March 25, 2011Publication date: July 11, 2013Applicant: LIQUID VANITY APSInventors: Dan Mønster Nielsen, Per Bendix Jeppesen, Allan Korsgaard Poulsen
-
Publication number: 20110038827Abstract: The present invention relates to the use of isosteviol, steviol, and related compounds for elevating the plasma HDL-cholesterol level. The invention furthermore relates to the use of these compounds for reducing the body weight of a subject and/or lowering the plasma triglyceride level of a subject, including a concomitant elevation of the plasma HDL-cholesterol level. Preferably the compounds used are isosteviol and/or steviol, or pharmaceutically acceptable salts, solvates or prodrugs thereof. The compounds may furthermore be administered in combination with one or more further active compounds, such as e.g. LDL-cholesterol lowering agents. The invention furthermore relates to a method for elevating the plasma HDL-cholesterol level in a subject by administering to a subject in need of such treatment a plasma HDL-cholesterol level elevating amount of the compounds, described herein.Type: ApplicationFiled: December 5, 2008Publication date: February 17, 2011Inventors: Kjeld Hermansen, Per Bendix Jeppesen
-
Publication number: 20100093861Abstract: The present invention relates to the use of a substance with the core structure of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the manufacture of a composition for the treatment of insulin resistance or diseases associated with insulin resistance, preferably in human subject in a daily dosage in a range of from about 5 mg to about 1500 mg. The invention furthermore relates to a method of treating insulin resistance or diseases associated with insulin resistance in a mammal, said method comprises administering to said mamma, preferably a human subject, a substance with the core structure of formula (I), preferably in a daily dosage in a range from about 5 mg to about 1500 mg. The substance is preferably isosteviol or steviol, or pharmaceutically acceptable salts, solvates or prodrugs thereof. Examples of diseases associated with insulin resistance are e.g.Type: ApplicationFiled: September 14, 2007Publication date: April 15, 2010Applicant: Stevia ApSInventors: Kjeld Hermansen, Per Bendix Jeppesen
-
Publication number: 20080318866Abstract: A substance including the chemical structures of bicyclo [3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo [3.2.1]octan alone or in a kaurene structure provides the substances, such as e.g. steviol, isosteviol and stevioside with the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the blood and/or lowering the blood pressure thereby providing a self-regulatory treatment system for non-insulin dependent diabetes mellitus and/or hypertension.Type: ApplicationFiled: August 7, 2008Publication date: December 25, 2008Inventors: Kjeld Hermansen, Soren Gregersen, Per Bendix
-
Publication number: 20040081712Abstract: A substance including the chemical structures of bicyclo[3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo[3.2.1]octan alone or in a kaurene structure provides the substances, such as steviol, isosteviol and stevioside, with the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the blood and/or lowering the blood pressure thereby providing a self-regulatory treatment system for non-insulin dependent diabetes mellitus and/or hypertension.Type: ApplicationFiled: July 31, 2003Publication date: April 29, 2004Inventors: Kjeld Hermansen, Soren Gregersen, Per Bendix Jeppesen, Lars H. Hoie